azacitidine,Sabatolimab
novartis
['azacitidine,(-oral azaci),(-azacitidine oral)', 'leukemia', 'mds', 'rp3 ']
disappointed to see the data from stimulus-mds1 presented by the one and only . sabatolimab/hma not significantly &gt; hma alone in hr-mds. interested in correlates &amp; predictors of response/durability. eagerly awaiting rp3 data of hma combos in #mds. #ash22 
Associate Prof of Med @UNC_Lineberger | Oncologist | Clinical Trialist- #AML & #MDS | Alum of Osler Residency & Hopkins Oncology | Diehard NYG fan| Views my own